Mid term swing opportunity in CTI BioPharma (CTIC)

Stock had decent drop right after earnings to the lowest channel support line.
Stock is heavily short : 20% of float is short
80% Institutional investors.
nice swing opportunity for a re-bounce to the upper "resistance" channel line.
NASDAQ:CTIC